TickerFactsScreenerDevelopers

Cartesian Therapeutics, Inc. (RNAC) — Net Income

Annual figures by fiscal year, from SEC filings.

2014: -$12.88M2015: -$25.17M2016: -$36.21M2017: -$65.32M2018: -$65.34M2019: -$55.35M2020: -$68.88M2021: -$25.69M2022: $35.38M2023: -$219.71M2024: -$77.42M2025: -$130.30M-$130.30M
2014Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$130.30M-68.3%
2024-$77.42M+64.8%
2023-$219.71M-721.0%
2022$35.38M+237.7%
2021-$25.69M+62.7%
2020-$68.88M-24.4%
2019-$55.35M+15.3%
2018-$65.34M-0.0%
2017-$65.32M-80.4%
2016-$36.21M-43.8%
2015-$25.17M-95.5%
2014-$12.88M—